Thomas E Bates, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3714 Guardian Ave Ste E, Morehead City, NC 28557 Phone: 252-247-2101 Fax: 252-247-4675 |
Robert Emmel Coles, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3714 Guardian Ave Ste E, Morehead City, NC 28557 Phone: 252-247-2101 Fax: 252-247-4675 |
Ashraf Faaek Guirgues, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3714 Guardian Ave, Ste E, Morehead City, NC 28557 Phone: 252-247-2101 Fax: 252-247-4675 |
Jeffrey K Moore, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4218-m Arendell St, Morehead City, NC 28557 Phone: 252-808-3100 Fax: 252-808-3120 |
News Archive
Giving blood more frequently – up to every 8 weeks for men and every 12 weeks for women – has no major side effects and could help to increase blood stocks, according to the first ever randomised trial of blood donation involving more than 45000 people in England published in The Lancet.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced that it has entered into a termination agreement with AstraZeneca, such that all the rights to Ardelyx's portfolio of NHE3 inhibitors, including Ardelyx's lead product candidate, tenapanor, are returned to Ardelyx.
HealthTrust Purchasing Group, L.P., has awarded Pioneer Surgical Technology, Inc. a spine implant agreement, beginning June 1, 2011.
In a new study, women who were more inclined to have one-night stands had wider hips, reveals Colin A. Hendrie of the University of Leeds in the UK. He is the lead author of a study into how a woman's build influences her sexual behavior, published in Springer's journal Archives of Sexual Behavior.
Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast to approach $3 billion in 2015.
› Verified 4 days ago